BAJAJ BROKING

Notification
No new Notification messages
Ajax Engineering IPO is Open!
Apply for the Ajax Engineering IPO through UPI in just minutes.
Q3 FY'25 Results of Top Companies!
From Reliance Industries to TCS to HDFC Bank, check out the latest quarterly results with financial highlights, key performance metrics, and more!
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
emcure pharmaceuticals limited stock

Emcure Pharmaceuticals Limited Share Price

1174.95 -37.80 (-3.11%)
Feb 10 2025 03:06 PM Pharmaceuticals NSE: EMCURE

Emcure Pharmaceuticals Limited Share Price Update

As of the latest trading session, Emcure Pharmaceuticals Limited share price is currently at 1174.95, which is down by -37.80 from its previous closing. Today, the stock has fluctuated between 1152.00 and 1213.00. Over the past year, Emcure Pharmaceuticals Limited has achieved a return of -10.77 %. In the last month alone, the return has been -14.63 %. Read More...

Emcure Pharmaceuticals Limited Performance

Day Range

Low1152.00 High1213.00
1175.70

52 Week Range

Low 1109.75 High 1580.00
1175.70

Emcure Pharmaceuticals Limited Share Price

24398

544210

EMCURE

img img img img
No Data Available

Open Price

1213.00

Prev. Close

1212.75

Volume (Shares)

96035.00

Total traded value

1129.08

Upper Circuit

1334.00

Lower Circuit

1091.50

Note: The current prices & values are delayed, Login to your account for live updates.

Emcure Pharmaceuticals Limited Fundamentals


(Standalone)

Market Cap (Cr) 21284.47
PE Ratio (TTM) 102.05
Book Value / Share 149.31
Beta 1.05
ROE 8.52%
EPS (TTM) 12.26
Dividend Yield 0.16%
Net Profit Qtr (Cr) 50.20

Emcure Pharmaceuticals Limited Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 3497.66
Operating Expense 3426.68
Net Profit 160.83
Net Profit Margin (%) 4.59
Earnings Per Share (EPS) 8.89
EBITDA 570.83
Effective Tax Rate (%) 19.54
Particulars MAR 2023 (Values in Cr)
Revenue 3107.09
Operating Expense 3013.95
Net Profit 160.06
Net Profit Margin (%) 5.15
Earnings Per Share (EPS) 9.07
EBITDA 557.69
Effective Tax Rate (%) 24.62
Particulars MAR 2022 (Values in Cr)
Revenue 3387.24
Operating Expense 2903.50
Net Profit 446.81
Net Profit Margin (%) 13.19
Earnings Per Share (EPS) 24.66
EBITDA 927.34
Effective Tax Rate (%) 27.51
Particulars MAR 2021 (Values in Cr)
Revenue 3153.66
Operating Expense 2689.83
Net Profit 420.48
Net Profit Margin (%) 13.33
Earnings Per Share (EPS) 23.25
EBITDA 837.03
Effective Tax Rate (%) 24.57
Particulars MAR 2020 (Values in Cr)
Revenue 2375.71
Operating Expense 2244.48
Net Profit 175.21
Net Profit Margin (%) 7.37
Earnings Per Share (EPS) 9.69
EBITDA 516.87
Effective Tax Rate (%) 22.02
Particulars MAR 2024 (Values in Cr)
Book Value / Share 106.82
ROE % 8.52
ROCE % 10.08
Total Debt to Total Equity 0.89
EBITDA Margin 16.32
Particulars MAR 2023 (Values in Cr)
Book Value / Share 101.84
ROE % 9.01
ROCE % 10.69
Total Debt to Total Equity 0.94
EBITDA Margin 17.95
Particulars MAR 2022 (Values in Cr)
Book Value / Share 94.69
ROE % 22.26
ROCE % 20.50
Total Debt to Total Equity 0.79
EBITDA Margin 27.38
Particulars MAR 2021 (Values in Cr)
Book Value / Share 127.27
ROE % 19.95
ROCE % 18.77
Total Debt to Total Equity 0.68
EBITDA Margin 26.72
Particulars MAR 2020 (Values in Cr)
Book Value / Share 105.86
ROE % 11.26
ROCE % 13.14
Total Debt to Total Equity 0.67
EBITDA Margin 23.79
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 232.40
Total Assets 7806.16
Total Liabilities 7806.16
Total Equity 3121.76
Share Outstanding 181152116
Price to Book Ratio 0.00
Return on Assets (%) 6.38
Return on Capital (%) 9.56
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 458.25
Total Assets 6672.53
Total Liabilities 6672.53
Total Equity 2649.66
Share Outstanding 180852116
Price to Book Ratio 0.00
Return on Assets (%) 7.97
Return on Capital (%) 10.98
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 313.29
Total Assets 6063.46
Total Liabilities 6063.46
Total Equity 2114.14
Share Outstanding 180852116
Price to Book Ratio 0.00
Return on Assets (%) 10.92
Return on Capital (%) 15.78
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 523.53
Total Assets 6807.39
Total Liabilities 6807.39
Total Equity 2368.01
Share Outstanding 180852116
Price to Book Ratio 0.00
Return on Assets (%) 6.14
Return on Capital (%) 9.68
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 163.83
Total Assets 6004.05
Total Liabilities 6004.05
Total Equity 1984.36
Share Outstanding 180852116
Price to Book Ratio 0.00
Return on Assets (%) 1.39
Return on Capital (%) 2.2
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 32.12
Total Assets 4756.93
Total Liabilities 4756.93
Total Equity 1935.09
Share Outstanding 181152116
Price to Book Ratio 0.00
Return on Assets (%) 3.38
Return on Capital (%) 4.8
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 141.01
Total Assets 4615.84
Total Liabilities 4615.84
Total Equity 1841.86
Share Outstanding 180852116
Price to Book Ratio 0.00
Return on Assets (%) 3.46
Return on Capital (%) 4.56
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 47.88
Total Assets 4323.18
Total Liabilities 4323.18
Total Equity 1712.52
Share Outstanding 180852000
Price to Book Ratio 0.00
Return on Assets (%) 10.33
Return on Capital (%) 13.58
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 260.72
Total Assets 4863.19
Total Liabilities 4863.19
Total Equity 2301.77
Share Outstanding 180852116
Price to Book Ratio 0.00
Return on Assets (%) 8.64
Return on Capital (%) 11.66
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 39.21
Total Assets 3871.20
Total Liabilities 3871.20
Total Equity 1914.55
Share Outstanding 180852116
Price to Book Ratio 0.00
Return on Assets (%) 4.52
Return on Capital (%) 5.98
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 53.24 30.60 2.90 408.00 39.20 / 77.70
BLISS GVS PHARMA LTD 149.70 19.62 1.56 1577.39 92.25 / 184.95
CIPLA LTD 1472.30 23.83 4.19 118905.02 1317.60 / 1702.00
FERMENTA BIOTECH LIMITED 391.30 135.87 3.96 1151.63 145.00 / 440.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 53.24 46.30 9.05 408.00 39.20 / 77.70
AMRUTAJAN HEALTH LTD 659.70 40.13 6.40 1907.23 574.45 / 861.40
ASTRAZENECA PHARMA IND LT 7639.45 148.37 28.11 19098.63 4050.15 / 8139.85
BLISS GVS PHARMA LTD 149.70 19.44 1.53 1577.39 92.25 / 184.95

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 1244.10
  • 26 Days 1297.50
  • 10 Days 1253.20
  • 50 Days 1332.70
  • 12 Days 1258.80
  • 100 Days 1356.90
  • 20 Days 1282.70
  • 200 Days 1375.10
1239.50
PIVOT
First Resistance 1283.25
Second Resistance 1353.75
Third Resistance 1397.50
First Support 1169.00
Second Support 1125.25
Third Support 1054.75
RSI 37.40
MACD -38.70
Commodity Channel Index (CCI) -57.40
ADX 51.02
Williams % R -59.57

Over 1 Month

down

-14.63

Over 3 Months

down

-15.76

Over 6 Months

down

-7.07

Over 1 Year

down

-10.77

Over 3 Years

down

0.00

Over 5 Years

down

0.00

Emcure Pharmaceuticals Limited Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

Emcure Pharmaceuticals Limited Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
15.14
Promoter Holdings
77.94
FII
3.04
DII
3.86
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Satish R Mehta Shareholding of Promoter and Promoter Group 7.5396748E7 39.8
Bc Investments Iv Limited Public Shareholding 1.6439459E7 8.68
Everest Trust (shares Held By Sanjay Rajanikant Mehta With Sonali Sanjay Mehta, As Trustees) Shareholding of Promoter and Promoter Group 1.452E7 7.67
Unity Trust (shares Held By Sunil Rajanikant Mehta With Kamini Sunil Mehta, As Trustees) Shareholding of Promoter and Promoter Group 1.4508E7 7.66
Samit S Mehta Shareholding of Promoter and Promoter Group 1.3537632E7 7.15
Bhavana Satish Mehta Shareholding of Promoter and Promoter Group 8916888.0 4.71
Namita Vikas Thapar Shareholding of Promoter and Promoter Group 5071200.0 2.68
Pushpa Rajnikant Mehta Shareholding of Promoter and Promoter Group 3886052.0 2.05
Sanjay Rajanikant Mehta Shareholding of Promoter and Promoter Group 3704028.0 1.96
Sunil Rajanikant Mehta Shareholding of Promoter and Promoter Group 2847012.0 1.5
Kamini Sunil Mehta Shareholding of Promoter and Promoter Group 1664960.0 0.88
Niraj Sunil Mehta Shareholding of Promoter and Promoter Group 1100000.0 0.58
Rutav Sunil Mehta Shareholding of Promoter and Promoter Group 988224.0 0.52
Vikas M Thapar Shareholding of Promoter and Promoter Group 645000.0 0.34
Surekha Umakant Shah Shareholding of Promoter and Promoter Group 318216.0 0.17
Suhasinee Saumil Shah Shareholding of Promoter and Promoter Group 129216.0 0.07
Smita Paresh Shah Shareholding of Promoter and Promoter Group 129216.0 0.07
Girish Harrai Desai Shareholding of Promoter and Promoter Group 115716.0 0.06
Shaila Sharad Gujar Shareholding of Promoter and Promoter Group 77530.0 0.04
Swati Hetalkumar Shah Shareholding of Promoter and Promoter Group 64716.0 0.03
Ranjanakumari Mukeshbhai Desai Shareholding of Promoter and Promoter Group 28928.0 0.02
The Ramni And Madan Thapar Revocable Living Trust Shareholding of Promoter and Promoter Group 0.0 0.0
Kaja Investments Llc Shareholding of Promoter and Promoter Group 0.0 0.0
Akanksha Eye Clinic & Nursing Home Shareholding of Promoter and Promoter Group 0.0 0.0
Sassy Stories Shareholding of Promoter and Promoter Group 0.0 0.0
Irrevocable Deed Of Trust Of Umakant Shah Shareholding of Promoter and Promoter Group 0.0 0.0
Himalayan Trust Shareholding of Promoter and Promoter Group 0.0 0.0
Sapphire Trust Shareholding of Promoter and Promoter Group 0.0 0.0
Menlo Trust Shareholding of Promoter and Promoter Group 0.0 0.0
Cayuga Trust Shareholding of Promoter and Promoter Group 0.0 0.0
Tulsi Trust Shareholding of Promoter and Promoter Group 0.0 0.0
Indus Trust Shareholding of Promoter and Promoter Group 0.0 0.0
H. M. Sales Corporation Shareholding of Promoter and Promoter Group 0.0 0.0
Heritage Pharma Holdings Inc. Shareholding of Promoter and Promoter Group 0.0 0.0
Thapar Vision Llp Shareholding of Promoter and Promoter Group 0.0 0.0
Incredible Ventures Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Incredible Ideas Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Avet Lifesciences Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Thapar Ventures Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Uth Beverage Factory Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Bhavna Battu Shareholding of Promoter and Promoter Group 0.0 0.0
Ramni Thapar Shareholding of Promoter and Promoter Group 0.0 0.0
Madan Mohan Thapar Shareholding of Promoter and Promoter Group 0.0 0.0
Jai Vikas Thapar Shareholding of Promoter and Promoter Group 0.0 0.0
Vir Vikas Thapar Shareholding of Promoter and Promoter Group 0.0 0.0
Aditi Shrivastav Shareholding of Promoter and Promoter Group 0.0 0.0
Malti Bharadwaj Shareholding of Promoter and Promoter Group 0.0 0.0
Akhil Bharadwaj Shareholding of Promoter and Promoter Group 0.0 0.0
Shaurya Samit Mehta Shareholding of Promoter and Promoter Group 0.0 0.0
Sunidhi Samit Mehta Shareholding of Promoter and Promoter Group 0.0 0.0
Abhilasha Samit Mehta Shareholding of Promoter and Promoter Group 0.0 0.0
Manish J. Shah Shareholding of Promoter and Promoter Group 0.0 0.0
Jigar J. Shah Shareholding of Promoter and Promoter Group 0.0 0.0
Pravina J. Shah Shareholding of Promoter and Promoter Group 0.0 0.0
Jashvantlal Hiralal Shah Shareholding of Promoter and Promoter Group 0.0 0.0

Emcure Pharmaceuticals Limited

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About Emcure Pharmaceuticals Limited

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by Emcure Pharmaceuticals Limited

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Emcure Pharmaceuticals Ltd?

Answer Field

The share price of Emcure Pharmaceuticals Ltd for NSE is ₹ 1174.95 and for BSE is ₹ 1174.9.

What is the Market Cap of Emcure Pharmaceuticals Ltd?

Answer Field

The market cap of Emcure Pharmaceuticals Ltd for NSE is ₹ 2,12,84.47 Cr. and for BSE is ₹ 2,12,83.56 Cr. as of now.

What is the 52 Week High and Low of Emcure Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Emcure Pharmaceuticals Ltd for NSE is ₹ 1580.00 and ₹ 1109.75 and for BSE is ₹ 1577.50 and ₹ 1110.00.

How to Buy Emcure Pharmaceuticals Ltd share?

Answer Field

You can trade in Emcure Pharmaceuticals Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Emcure Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been -10.77%.

What is the Current Share Price of Emcure Pharmaceuticals Ltd?

Answer Field

Emcure Pharmaceuticals Ltd share price is for NSE ₹ 1174.95 & for BSE ₹ 1174.9 as on Feb 10 2025 03:06 PM.

What is the Market Cap of Emcure Pharmaceuticals Ltd Share?

Answer Field

The market cap of Emcure Pharmaceuticals Ltd for NSE ₹ 2,12,84.47 & for BSE ₹ 2,12,83.56 as on Feb 10 2025 03:06 PM.

What is the P/E Ratio of Emcure Pharmaceuticals Ltd Share?

Answer Field

As on Feb 10 2025 03:06 PM the price-to-earnings (PE) ratio for Emcure Pharmaceuticals Ltd share is 102.05.

What is the PB ratio of Emcure Pharmaceuticals Ltd Share?

Answer Field

As on Feb 10 2025 03:06 PM, the price-to-book (PB) ratio for Emcure Pharmaceuticals Ltd share is 149.31.

How to Buy Emcure Pharmaceuticals Ltd Share?

Answer Field

You can trade in Emcure Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Emcure Pharmaceuticals Ltd Share on Bajaj Broking App?

Answer Field

To buy Emcure Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Emcure Pharmaceuticals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

9 Lacs+ Users

icon-with-text

4.1+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5100+ Cr MTF Book

icon-with-text
loader